PARALLEL ASSESSMENT OF GLUTATHIONE-BASED DETOXIFYING ENZYMES, O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND P-GLYCOPROTEIN AS INDICATORS OF DRUG-RESISTANCE IN TUMOR AND NORMAL LUNG OF PATIENTS WITH LUNG-CANCER

被引:43
作者
OBERLISCHRAMMLI, AE
JONCOURT, F
STADLER, M
ALTERMATT, HJ
BUSER, K
RIS, HB
SCHMID, U
CERNY, T
机构
[1] UNIV BERN,DEPT CLIN EXPTL RES,CH-3004 BERN,SWITZERLAND
[2] UNIV BERN,DEPT PATHOL,CH-3000 BERN,SWITZERLAND
[3] UNIV BERN,DEPT MED ONCOL,BERN,SWITZERLAND
[4] UNIV BERN,INSELSPITAL,DEPT THORAC & CARDIOVASC SURG,BERN,SWITZERLAND
[5] KANTONSSPITAL,INST PATHOL,ST GALLEN,SWITZERLAND
关键词
D O I
10.1002/ijc.2910590509
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The levels of several potential indicators of drug resistance were measured in tumor and corresponding normal tissue of 55 untreated patients with lung cancer. The resistance parameters include glutathione (GSH) level, activities of the enzymes glutathione transferase (GST), glutathione peroxidase (GPx) and O-6-alkylguanine-DNA alkyltransferase (ATase), as well as expression of P-glycoprotein (Pgp). Median values of GSH, GST and GPx were significantly higher in tumor than in normal tissue of non-small-cell lung cancer (NSCLC) or of small-cell lung cancer (SCLC), whereas ATase was elevated in tumor tissue of NSCLC only. Pgp expression as determined by Western blotting was significantly lower in tumor than in normal tissue of NSCLC. Resistance-parameter expression did not correlate with stage of disease or age of the patients. We found a negative correlation between smoking intensity and GSH level in normal tissue. Our findings indicate that the fundamental differences in chemosensitivity between SCLC and NSCLC cannot be explained by differences in the GSH-system or in the expression of Pgp. However, the level of ATase activity may be one of the factors responsible for the difference in chemosensitivity. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:629 / 636
页数:8
相关论文
共 39 条
[1]   ISOLATION AND GENETIC-CHARACTERIZATION OF HUMAN KB-CELL LINES RESISTANT TO MULTIPLE-DRUGS [J].
AKIYAMA, SI ;
FOJO, A ;
HANOVER, JA ;
PASTAN, I ;
GOTTESMAN, MM .
SOMATIC CELL AND MOLECULAR GENETICS, 1985, 11 (02) :117-126
[2]  
[Anonymous], 1982, Am J Clin Pathol, V77, P123
[3]  
BAAS F, 1990, CANCER RES, V50, P5392
[4]   THE ROLE OF GLUTATHIONE-DEPENDENT ENZYMES IN DRUG-RESISTANCE [J].
BLACK, SM ;
WOLF, CR .
PHARMACOLOGY & THERAPEUTICS, 1991, 51 (01) :139-154
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   GLUTATHIONE S-TRANSFERASE ISOENZYMES AND GLUTATHIONE-PEROXIDASE ACTIVITY IN NORMAL AND TUMOR SAMPLES FROM HUMAN-LUNG [J].
CARMICHAEL, J ;
FORRESTER, LM ;
LEWIS, AD ;
HAYES, JD ;
HAYES, PC ;
WOLF, CR .
CARCINOGENESIS, 1988, 9 (09) :1617-1621
[7]  
CHEN JM, 1992, CARCINOGENESIS, V13, P1503
[8]   STRUCTURE AND EXPRESSION OF THE HUMAN MDR (P-GLYCOPROTEIN) GENE FAMILY [J].
CHIN, JE ;
SOFFIR, R ;
NOONAN, KE ;
CHOI, K ;
RONINSON, IB .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (09) :3808-3820
[9]   O6-METHYLGUANINE-DNA METHYLTRANSFERASE IN HUMAN NORMAL AND MALIGNANT LUNG TISSUES [J].
CITRON, M ;
SCHOENHAUS, M ;
GRAVER, M ;
HOFFMAN, M ;
LEWIS, M ;
WASSERMAN, P ;
NIEDERLAND, M ;
KAHN, L ;
WHITE, A ;
YAROSH, D .
CANCER INVESTIGATION, 1993, 11 (03) :258-263
[10]  
COOK JA, 1991, CANCER RES, V51, P4287